| Net income | 891K |
| Depreciation and amortization | 649K |
| Stock-based compensation expense | 984K |
| Other non-cash adjustments | |
| Deferred income tax expense | 280K |
| Trade accounts receivable | -13K |
| Prepaid expenses and other current assets | -259K |
| Accounts payable and accrued liabilities | -757K |
| Deferred revenue | -620K |
| Net cash provided by operations | 1.24M |
| Purchases of property and equipment | -376K |
| Sales and purchases of marketable securities, net | 13.51M |
| Decrease in other assets | |
| Net cash provided by (used in) investing activities | 13.14M |
| Proceeds from exercise of stock options | 2.1M |
| Purchase of treasury stock | -3K |
| Net cash provided by (used in) financing activities | 2.09M |
| Effect of exchange rate on cash and cash equivalents | -5K |
| Increase (decrease) in cash and cash equivalents | 16.47M |
| Cash and cash equivalents of beginning of period | 11.12M |
| Cash and cash equivalents at end of period | 27.59M |